Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BAC has entered into a strategic collaboration with Life Technologies to bring the BAC’s CaptureSelect affinity ligand specificities to Life Technologies’ POROS chromatography media and pre-packed HPLC columns.
Subscribe to our email newsletter
BAC’s CaptureSelect affinity purification and separation products are provided for the discovery, preclinical and clinical manufacturing of therapeutic proteins, including antibodies and antibody fragments.
The collaboration creates a HPLC columns pre-packed with CaptureSelect affinity ligands immobilized on POROS chromatography media.
The selectivity of these columns will support process analytical technology (PAT) for any biopharmaceutical manufacturing process.
BAC CEO Laurens Sierkstra said providing specificities and column formats will allow more researchers to access the benefits of CaptureSelect technology.
"Scientists will be able to use CaptureSelect ligands in formats that support QbD approaches for process development and monitoring," Sierkstra said.